https://www.ndtvprofit.com/quarterly-earnings/stress-in-distribution-channels-hurt-ciplas-india-sales-in-q1?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The company’s India business was also impacted by deferral of branded generics sales, says managing director Umang Vohra.